Cardiovascular Systems, Inc. CSII recently announced an acquisition option agreement with Chansu Vascular Technologies, LLC (CVT) for the development of a peripheral everolimus drug-coated balloon ...
With the help of a small California startup, Cardiovascular Systems has laid out plans to build a full portfolio of minimally invasive medical hardware designed to remove blood clots. The devicemaker ...
Illinois-based medical technology giant Abbott will acquire New Brighton-based medical device company Cardiovascular Systems Inc., the companies announced Wednesday. Under the terms of the agreement, ...
Historically, much of the research conducted in our 'Heart Lab' has been at the interface of medicine and engineering, dedicated to the discovery and development of innovative methodologies (molecular ...
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...
TYLER, Texas--(BUSINESS WIRE)-- NanoVibronix, Inc. (NAOV) (“NanoVibronix” or the “Company”), a medical technology company specializing in non-invasive therapeutic systems, today announced the official ...
The field of tumor microenvironment research has increasingly highlighted the intertwined relationship between aberrant vasculature and dysregulated immune ...
The costliness of drug development and the limitations of studying physiological processes in the lab are two separate scientific issues that may share the same solution. Microphysical systems (MPSs) ...
Cardiovascular Systems, Inc. CSII recently completed a minority investment and inked an acquisition option agreement with CarePICS, LLC. Notably, Cardiovascular Systems also has an exclusive option to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results